Avlar BioVentures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 34

  • Portfolio
  • 3

  • Exits
  • 20


Avlar BioVentures General Information

Company Description

Avlar BioVentures was a Cambridge, United Kingdom based venture capital firm. The firm primarily makes early stage and seed investments and targets the biotechnology and healthcare sectors.

Business Details

Year Founded
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • Highfield Court
  • Madingley
  • Cambridge CB23 8AG
  • England, United Kingdom

Avlar BioVentures Investments (34)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Crescendo Biologics 05-Oct-2012 Later Stage VC 00.000 Drug Discovery Clinical Trials - Phase 1 0000 0000000
TeraView 23-Dec-2011 00000 00000 00.00 Electronic Equipment and Instruments Generating Revenue
Amura 31-Jan-2011 00000 00000 Drug Discovery Out of Business 0000 0000000
Crescendo Biologics 12-Oct-2009 0000 00000 00.000 Drug Discovery Clinical Trials - Phase 1 0000 0000000
York Pharma 01-Oct-2008 00000 00000 000.00 Distributors (Healthcare) Out of Business
Medical Device Innovations 11-Mar-2008 00000 00000 00.000 Therapeutic Devices Out of Business
Medical Device Innovations 01-Mar-2007 00000 00000 00.000 Therapeutic Devices Out of Business
CellCentric 18-Jul-2006 00000 00000 00.00 Biotechnology Clinical Trials - Phase 1
Paradigm Therapeutics 07-Jul-2006 Later Stage VC 000.00 Drug Discovery Generating Revenue 0000 0000000
Aitua 01-Jun-2006 Joint Venture 00.000 Private Equity Out of Business
You’re viewing 10 of 34 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avlar BioVentures Exits (20)

Company Name Exit Date Exit Type Exit Size
Paion 26-Oct-2023 Bankruptcy: Admin/Reorg
Amura 01-Nov-2017 000 00 00000000
De Novo Pharmaceuticals 01-Aug-2015 000 00 00000000
Medical Device Innovations 01-Jun-2014 000 00 00000000
NXVision 15-Sep-2010 000000000000000000 000.00
Purely Proteins 16-Jul-2010 0000000000: 000000
Intercytex 30-Jun-2010 000 000.00
Aitua 01-Mar-2010 000 00 00000000
Velocix 28-Jul-2009 Merger/Acquisition
York Pharma 27-Jul-2009 Bankruptcy: Liquidation
You’re viewing 10 of 20 exits. Get the full list »

Avlar BioVentures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Avlar BioVentures‘s full profile, request access.

Request a free trial

Avlar BioVentures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »